Jun Haeng Lee
Jun Haeng Lee publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Gastroenterology, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Helicobacter pylori-related gastroenterology studies.
- World rank
- #1,457,747 of 7,710,434 ranked researchers
- Rank in South Korea
- #16,281 of 162,609
- Works
- 407
- Citations
- 8.5k
- Citations per work
- 20.9
What does Jun Haeng Lee research?
Jun Haeng Lee's work is mostly in Medicine (69%), Engineering (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences28269.3%
- Medicine28269.3%
- Everything else10325.4%
- Physical Sciences225.3%
- Engineering225.3%
- 1Surgery26% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Gastroenterology13% of their works
- 4Oncology6% of their works
- 5Electrical and Electronic Engineering5% of their works
- 6Epidemiology4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Helicobacter pylori-related gastroenterology studies
- Gastrointestinal Tumor Research and Treatment
- Metastasis and carcinoma case studies
- Gastroesophageal reflux and treatments
- Esophageal and GI Pathology
- Colorectal Cancer Screening and Detection
Which keywords describe Jun Haeng Lee's research?
The keywords of their largest research topics: Endoscopic Resection, Gastric Cancer, Chemotherapy, Molecular Characterization, Epidemiology, Prevention, Esophageal Carcinoma and Preoperative Chemoradiotherapy.
- Screening
- Esophageal Perforation
- Gastroesophageal Reflux Disease
- Metastatic Carcinomas
- Sunitinib
- Inflammation
- Preoperative Chemoradiotherapy
- Prevention
- Molecular Characterization
- Gastric Cancer
- Endoscopic Resection
- Chemotherapy
- Epidemiology
- Esophageal Carcinoma
- Helicobacter pylori
- Imatinib Mesylate
- Lung Tumors
- Esophageal Motility Disorders
- Endoscopic Stenting
- Colorectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Endoscopic Resection2672 topics
- Gastric Cancer2552 topics
- Chemotherapy1761 topic
- Molecular Characterization1761 topic
- Epidemiology1312 topics
- Prevention1052 topics
- Esophageal Carcinoma911 topic
- Preoperative Chemoradiotherapy911 topic
- Helicobacter pylori791 topic
- Inflammation791 topic
- Imatinib Mesylate781 topic
- Sunitinib781 topic
- Lung Tumors501 topic
- Metastatic Carcinomas501 topic
- Esophageal Motility Disorders401 topic
- Gastroesophageal Reflux Disease401 topic
- Endoscopic Stenting371 topic
- Esophageal Perforation371 topic
- Colorectal Cancer261 topic
- Screening261 topic
Where does Jun Haeng Lee work?
Jun Haeng Lee's main affiliation in the publication record is Samsung Medical Center, South Korea.
How many publications and citations does Jun Haeng Lee have?
OpenAlex counts 407 works and 8,514 citations for Jun Haeng Lee, an h-index of 45, ranking #1,457,747 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jun Haeng Lee
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jun Haeng Lee. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.